Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat

• Published in: Peritoneal dialysis international Vol. 24; no. 2; pp. 115 - 122
• Main Authors: Park, SH, Lee, EG, Kim, IS, Kim, YJ, Cho, DK, Kim, YL
• Format: Journal Article
• Language: English
• Published: Milton, ON Multimed 01.03.2004
• Subjects: Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Animals; Biological and medical sciences; Dialysis Solutions - pharmacology; Disease Models, Animal; Emergency and intensive care: renal failure. Dialysis management; Glomerulonephritis; Glucose - pharmacology; Glycation End Products, Advanced - pharmacology; Intensive care medicine; Male; Medical sciences; Nephrology. Urinary tract diseases; Nephropathies. Renovascular diseases. Renal failure; Peritoneal Dialysis; Peritoneum - blood supply; Peritoneum - drug effects; Peritoneum - metabolism; Peritonitis - metabolism; Peritonitis - pathology; Permeability - drug effects; Rats; Rats, Sprague-Dawley; Renal failure; Transforming Growth Factor beta - metabolism; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A - metabolism; Rat; Glucose; peritoneal transport; Peritoneal dialysis; Vascularization; Extrarenal dialysis; Infusion; Blood vessel; Membrane; Kidney disease; Urinary system disease; Rodentia; Inflammation; Glucose degradation products; Endothelium; Vertebrata; Chronic; Mammalia; Perfusion; Animal; vascular endothelial growth factor; Renal failure; Models; Transport; Degradation product; Growth factor; Peritoneum
• ISSN: 0896-8608; 1718-4304
• DOI: 10.1177/089686080402400202

Division of Nephrology, Department of Internal Medicine, Kyungpook National University, School of Medicine, Daegu, Korea.